Live Breaking News & Updates on Kuros Biosciences Kuro

Stay updated with breaking news from Kuros biosciences kuro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management

Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management
californiatelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from californiatelegraph.com Daily Mail and Mail on Sunday newspapers.

United States , Kuros Biosciences , Van Dijk , Kuros Biosciences Kuro , Clemens Van Blitterswijk , Swiss Exchange , Medical Devices , Executive Management , Executive Director , Chris Fair , Chief Executive , Chief Operating Officer , Chief Executive Officer , Kuros Board , Xpand Biotechnology , John Griffin , Chief Commercial Officer , Sjoerd Musters , Biomed Mater ,

Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications 21-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Clearance . ....

United States , Kuros Biosciences Kuro , Hans Herklots , Michael Grau , Van Dijk , Kuros Biosciences , Drug Administration , News Service , Swiss Exchange , Magnetos Flex Matrix Cleared , Spinal Indications , Magnetos Flex Matrix , Magnetos Granules , Magnetos Putty , Magnetos Easypack Putty , Chief Executive Officer , Sci Advisors , Iosciences S , Et Cest ,

Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications

Kuros Biosciences AG / Key word(s): Miscellaneous03.02.2022 / 07:00 Rare clearance for bone graft for standalone use in spine based on human clinical data Clearance attained with evidence from Level 1 randomized controlled trial Positions MagnetOs above most other 510(k)-cleared bone grafts on the market Schlieren. ....

United States , Kuros Biosciences Kuro , Hans Herklots , Michael Grau , Kuros Biosciences , Company Project Fusion , Drug Administration , Swiss Exchange , Magnetos Granules , Chief Executive Officer , Project Fusion , Sci Advisors ,

Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences s MagnetOs Granules cleared by FDA for expanded spinal indications 03.02.2022 / 07:00 Rare clearance for bone graft for standalone use in spine based on human clinical data Clearance attained with evidence from Level 1 randomize. ....

United States , Kuros Biosciences Kuro , Hans Herklots , Michael Grau , Kuros Biosciences , Company Project Fusion , Drug Administration , News Service , Swiss Exchange , Magnetos Granules , Chief Executive Officer , Project Fusion , Sci Advisors , Iosciences S ,